Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3663)

[1021]

aut. Lemež, P.

The occurrence of T-cell malignancies in patients treated by chemotherapy for acute myeloid leukemia

[year of publication 2006, impact factor 1.475]

[1022]

Lacina, L.; Dvořánková, B.; Smetana, K. Jr.; Chovanec, M.; Plzák, J.; Tachezy, R.; Kideryová, L.; Kučerová, L.; Čada, Z.; Bouček, J.; Kodet, R.; André, S.; Gabius, H. J.

Marker profiling of normal keratinocytes identifies the stroma from squamous cell carcinoma of the oral cavity as a modulatory microenvironment in co-culture.

[year of publication 2008, impact factor 1.468]

[1023]

Pavlistova, L.; Izakova, S.; Zemanova, Z.; Bartuskova, L.; Langova, M.; Malikova, P.; Michalova, K.

Rare congenital chromosomal aberration dic(X;Y)(p22.33;p11.32) in a patient with primary myelofibrosis

[year of publication 2016, impact factor 1.455 ]

[1024]

Lhotska, H.; Zemanova, Z.; Cechova, H.; Ransdorfova, S.; Svobodova, K.; Kramar, F.; Krejcik, Z.; Michalova, K.

Primary and recurrent diffuse astrocytomas: genomic profile comparison reveals acquisition of biologically relevant aberrations

[year of publication 2016, impact factor 1.455 ]

[1025]

Kalousek, I.; Krížková, P.

Lymphocyte mitogenic transformation is accompanied by phosphorylation of the nucleolar transcription factor UBF

[year of publication 2006, impact factor 1.449]

[1026]

Figova, K.; Sobotkova, E.; Duskova, M.; Ludvikova, V.; Vonka, V.; Eckschlager, T.

In vitro and in vivo effects of reovirus on HPV16-transformed mice cells

[year of publication 2010, impact factor 1.449]

[1027]

Votavova, H.; Forsterova, K.; Campr, V.; Sritesky, J.; Velenska, Z.; Pytlik, R.; Kubackova, K.; Prochazka, B.; Kodet, R.; Spicka, I.; Krejcova, H.; Trneny, M.; Klener, P.

Distinguishing of primary mediastinal B-cell lymphoma and diffuse large B-cell lymphoma using real-time quantitative polymerase chain reaction

[year of publication 2010, impact factor 1.449]

[1028]

Szotkowski, T.; Muzik, J.; Voglova, J.; Koza, V.; Maaloufova, J.; Kozak, T.; Jarosova, M.; Michalova, K.; Zak, P.; Steinerova, K.; Vydra, J.; Lanska, M.; Katrincsakova, B.; Sicova, K.; Pavlik, T.; Dusek, L.; Indrak, K.

Prognostic factors and treatment outcome in 1,516 adult patients with de novo and secondary acute myeloid leukemia in 1999-2009 in 5 hematology intensive care centers in the Czech Republic

[year of publication 2010, impact factor 1.449]

[1029]

Smetana, K.; Karban, J.; Trneny, M.

To the nucleolar bodies (nucleoli) in cells of the lymphocytic lineage in patients suffering from B – chronic lymphocytic leukemia

[year of publication 2010, impact factor 1.449]

[1030]

Březinová, J.; Berková, A.; Včelíková, S.; Zemanová, Z.; Izáková, S.; Šárová, I.; Čechová, H.; Tajtlová, J.; Grosová, L.; Lizcová, L.; Malinová, E.; Zemanová, M.; Cmunt, E.; Karban, J.; Trněný, M.; Schwarz, J.; Michalová, K.

Telomere length, molecular cytogenetic findings, and immunophenotypic features in previously untreated patients with B-chronic lymphocytic leukemia

[year of publication 2009, impact factor 1.449]

[1031]

Klamova, H.; Faber, E.; Zackova, D.; Markova, M.; Voglova, J.; Cmunt, E.; Novakova, L.; Machova-Polakova, K.; Moravcova, J.; Dvorakova, D.; Michalova, K.; Brezinova, J.; Oltova, A.; Jarosova, M.; Cetkovsky, P.; Indrak, K.; Mayer, J.

Dasatinib in imatinib-resistant or -intolerant CML patients : data from the clinical practice of 6 hematological centers in the Czech Republic

[year of publication 2010, impact factor 1.449]

[1032]

Tachezy, R.; Klozar, J.; Saláková, M.; Smith, E.; Turek, L.; Betka, J.; Kodet, R.; Hamšíková, E.:

HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic.

[year of publication 2006, impact factor 1.445]

[1033]

Dyr, J.E.; Ryšavá, J.; Suttnar, J.; Homola, J.; Tobiška, P.

Optical sensing of the initial stages in the growth and development of fibrin clot

[year of publication 2006, impact factor 1.440]

[1034]

Voglova, J.; Muzik, J.; Faber, E.; Zackova, D.; Klamova, H.; Steinerova, K.; Michalovicova, Z.; Demitrovicova, L.; Cmunt, E.; Novakova, L.; Tothova, E.; Belohlavkova, P.; Mayer, J.; Indrak, K.

Incidence of second malignancies during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors in the Czech Republic and Slovakia

[year of publication 2012, impact factor 1.440 ]

[1035]

Smetana, K.; Karban, J.; Trneny, M.

Heterochromatin condensation in central and peripheral nuclear regions of maturing lymphocytes in the peripheral blood of patients suffering from B chronic lymphotic leukemia: a cytochemical study

[year of publication 2011, impact factor 1.440 ]

[1036]

Elknerova, K.; Myslivcova, D.; Lacinova, Z.; Marinov, I.; Uherkova, L.; Stockbauer, P.

Epigenetic modulation of gene expression of human leukemia cell lines - induction of cell death and senescence

[year of publication 2011, impact factor 1.440 ]

[1037]

Zurkova, K.; Chlanda, P.; Samkova, Z.; Babiarova, K.; Kutinova, L.; Krystofova, J.; Hainz, P.; Nemeckova, S.

Expression of soluble TGF-beta receptor II by recombinant Vaccinia virus enhances E7 specific immunotherapy of HPV16 tumors

[year of publication 2011, impact factor 1.440 ]

[1038]

Svobodová, H.; Štulc, T.; Kasalová, Z.; Doležalová, R.; Marinov, I.; Čapek, P.; Češka, R.

The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitus.

[year of publication 2010, impact factor 1.430]

[1039]

Neuwirtová, R.; Móciková, K.; Musilová, J.; Jelínek, J.; Havlíček, V.; Michalová, K.; Adamkov, M.

Mixed myelodysplastic and myeloproliferative syndromes

[year of publication 2006, impact factor 1.423]

[1040]

Tachezy, R.; Jirasek, T.; Salakova, M.; Ludvikova, V.; Kubecova, M.; Horak, L.; Mandys, V.; Hamsikova, E.

Human papillomavirus infection and tumours of the anal canal : correlation of histology, PCR detection in paraffin sections and serology

[year of publication 2007, impact factor 1.421]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 305

Deputy head of Science and Research Division
Tel:+420 221 977 648

Secretary
Tel:+420 221 977 144


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here